Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis
article
OA: gold
CC0
⤵ 10 in-corpus citations
Abstract
Adenomyosis is a common gynecologic disorder characterized by the presence of endometrial glands and stroma within the myometrium. The present study investigated the effect of quercetin in neonatal Imprinting Control Region mice with tamoxifen‑induced adenomyosis. The body weight and hotplate response latency of all mice was examined at 4, 8, 12 and 16 weeks after birth. The mice dosed with tamoxifen were divided into four groups: high‑ or low‑quercetin group, valproic acid (VPA) group and untreated group. The group of mice that were neonatally administrated with the solvent only (no tamoxifen), received no treatment and served as a blank control group. After 3 weeks of drug treatment, the potential ability of quercetin to improve the generalized hyperalgesia in mice with induced adenomyosis was evaluated by determining the body weight, pain modulation, examining the myometrial infiltration by histology examination of the uterus and detecting the expression of transient receptor potential cation channel subfamily V member 1 (Trpv‑1), phospho (p)‑p38 mitogen activated protein kinase p‑extracellular signal‑regulated kinase (p‑ERK) in DRG neurons via immunohistochemistry. The results demonstrated that treatment with quercetin improved the generalized hyperalgesia by extending the hotplate response latency, reduced myometrial infiltration and decreased the expression levels Trpv‑1, p‑p38 and p‑ERK in dorsal root ganglion neurons. The results indicated that quercetin decreases the incidence of hyperalgesia in mice with tamoxifen‑induced adenomyosis, and the potential mechanism is through reduced central sensitization, which may be a promising treatment for adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Adenomyosis and its impact on women fertility. via openalex
- Adenomyosis—A Result of Disordered Stromal Differentiation via openalex
- Comparative immunohistochemical studies of <i>bcl</i>‐2 and p53 proteins in benign and malignant ovarian endometriotic cysts via openalex
- Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality. via openalex
- Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis via openalex
- LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis via openalex
- MR imaging of diffuse adenomyosis changes after GnRH analog therapy via openalex
- Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer via openalex
- Survivin Gene Expression in Endometriosis via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis via openalex
- W2061448291 via openalex
- W2113266502 via openalex
- W2121836743 via openalex
- W2123392388 via openalex
- W2132187713 via openalex
- W2257296467 via openalex
- W2297606889 via openalex
- W2318308464 via openalex
- W4302219957 via openalex
- W4406058850 via openalex
- W6678913744 via openalex
- W1503834335 via openalex
- W6716137216 via openalex
- W1973217858 via openalex
- W1984488694 via openalex
- W2003982930 via openalex
- W2027968437 via openalex
- W2032799645 via openalex
- W2033363713 via openalex
- W2038354928 via openalex
- W2051910399 via openalex
- W2052379093 via openalex
- W2058170926 via openalex
Cited by (10)
- A Review of the Potential Therapeutic Benefits of Quercetin for Uterine-Related Conditions 2026
- Research Progress of Traditional Chinese Medicine in the Treatment of Adenomyosis-Related Signaling Pathways 2026
- Drug development for adenomyosis based on pathophysiology 2025
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding 2023
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis 2021
- Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis 2021
- Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model 2020
- Novel dietary supplement association reduces symptoms in endometriosis patients 2017
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:19.560968+00:00
License: CC0
· commercial use OK